- Home
- STRO vs ZURA Comparison
STRO vs ZURA Comparison
Compare STRO & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- ZURA
- Stock Information
- Founded
- STRO 2003
- ZURA 2022
- Country
- STRO United States
- ZURA United States
- Employees
- STRO N/A
- ZURA N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STRO Health Care
- ZURA Health Care
- Exchange
- STRO Nasdaq
- ZURA Nasdaq
- Market Cap
- STRO 292.6M
- ZURA 292.1M
- IPO Year
- STRO 2018
- ZURA N/A
- Fundamental
- Price
- STRO $2.84
- ZURA $2.88
- Analyst Decision
- STRO Strong Buy
- ZURA Buy
- Analyst Count
- STRO 7
- ZURA 6
- Target Price
- STRO $12.14
- ZURA $15.80
- AVG Volume (30 Days)
- STRO 1.0M
- ZURA 377.1K
- Earning Date
- STRO 11-13-2024
- ZURA 11-07-2024
- Dividend Yield
- STRO N/A
- ZURA N/A
- EPS Growth
- STRO N/A
- ZURA N/A
- EPS
- STRO N/A
- ZURA N/A
- Revenue
- STRO $160,955,000.00
- ZURA N/A
- Revenue This Year
- STRO N/A
- ZURA N/A
- Revenue Next Year
- STRO N/A
- ZURA N/A
- P/E Ratio
- STRO N/A
- ZURA N/A
- Revenue Growth
- STRO 230.90
- ZURA N/A
- 52 Week Low
- STRO $2.45
- ZURA $2.00
- 52 Week High
- STRO $6.13
- ZURA $6.35
- Technical
- Relative Strength Index (RSI)
- STRO 41.69
- ZURA 36.44
- Support Level
- STRO $2.66
- ZURA $2.71
- Resistance Level
- STRO $2.86
- ZURA $2.87
- Average True Range (ATR)
- STRO 0.19
- ZURA 0.23
- MACD
- STRO 0.02
- ZURA -0.01
- Stochastic Oscillator
- STRO 78.00
- ZURA 31.51
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About ZURA Zura Bio Limited
Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders.